These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4770405)

  • 21. [The effect of drugs on platelet function].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):448-59. PubMed ID: 4193161
    [No Abstract]   [Full Text] [Related]  

  • 22. The preventive effect of a low-molecular pentosan-polysulphate on DAS-induced increase in pulmonary vascular resistance caused by platelet-aggregation.
    Schumacher KA; Classen HG
    Arzneimittelforschung; 1973 Mar; 23(3):431-3. PubMed ID: 4740131
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
    Cepeláková H; Roubal Z; Grimová J; Dlabac A; Cepelák V
    Acta Univ Carol Med Monogr; 1972; 52():55-60. PubMed ID: 4669827
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of platelet aggregation by anti-5-hydroxytryptaminic and alpha-adrenergic blocking agents.
    Fregnan GB
    Acta Univ Carol Med Monogr; 1972; 53():263-8. PubMed ID: 4151573
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-thrombotic activity of a benzo(c)(1,6)naphthyridine.
    Ott H; Smith GM
    Br J Pharmacol; 1971 Oct; 43(2):460P-461P. PubMed ID: 5158236
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of adenosine monophosphate, arcaine and anti-inflammatory agents on thrombosis and platelet function in rabbits.
    Peterson J; Zucker MB
    Thromb Diath Haemorrh; 1970 Feb; 23(1):148-58. PubMed ID: 4911827
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet reactivity ex vivo and in vivo after acute and chronic treatment with sodium caprylate.
    Tangen O; Wallenbeck IA; Bergqvist D
    Scand J Clin Lab Invest; 1975 Jan; 35(1):19-23. PubMed ID: 1129590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of stachydrine alkaloid on the blood coagulation system].
    Mansurov MM
    Farmakol Toksikol; 1972; 35(6):715-7. PubMed ID: 4651807
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of a new anti-inflammatory agent (5-cyclohexylindan-1-carboxylic acid (BL-2365)) on platelet aggregation.
    Fleming JS; Bierwagen ME; Campbell JA; King SP
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):164-71. PubMed ID: 5072183
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of prostaglandins E1 and E2 on platelet aggregation in mammals.
    Sinakos Z; Zamboulis C; Kartalis G; Koratzis J; Valtis D
    Haematologica; 1974 Jun; 59(2):173-80. PubMed ID: 4216529
    [No Abstract]   [Full Text] [Related]  

  • 33. A model for quantitating in vivo platelet aggregation.
    Solis RT; Wright CB; Gibbs MB
    Bibl Anat; 1973; 12():223-8. PubMed ID: 4790355
    [No Abstract]   [Full Text] [Related]  

  • 34. The inhibition of platelet aggregation by an aorta intima extract.
    Heyns AP; van den Berg DJ; Potgieter GM; Retief FP
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):417-31. PubMed ID: 4450195
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibitors of platelet aggregation. 1. 5,10-Dihydro-3-(phenyl, thienyl, and furyl)thiazolo(3,2-b)(2,4)benzodiazepines and related compounds.
    Elslager EF; McLean JR; Perricone SC; Potoczak D; Veloso H; Worth DF; Wheelock RH
    J Med Chem; 1971 May; 14(5):397-401. PubMed ID: 5117685
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of the infusion of adenosine diphosphate (ADP) in the lingual artery of rabbits. II. Observations of platelet emboli through a cranial window].
    Zanette E; Cavallini C; Fieschi C; Battistini N; Fontani G; Weber G
    Boll Soc Ital Biol Sper; 1973 Feb; 49(4):206-9. PubMed ID: 4779766
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyperfunction of blood platelets and suppressive agents].
    Yasunaga K; Ryo T
    Rinsho Ketsueki; 1975 Apr; 16(4):396-407. PubMed ID: 1170359
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annual oration on small cells and great problems.
    Born GV
    Trans Med Soc Lond; 1982-1984; 99-100():44-52. PubMed ID: 6765412
    [No Abstract]   [Full Text] [Related]  

  • 40. Potentiating effect of adenosine on other inhibitors of platelet aggregation.
    Murakami M; Odake K; Takase M; Yoshino K
    Thromb Diath Haemorrh; 1972 Apr; 27(2):252-62. PubMed ID: 5049615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.